Literature DB >> 7511265

[Immunohistochemical and morphometric studies on neuroendocrine differentiation of prostate carcinomas].

M H Bohrer1, J Schmoll.   

Abstract

102 unselected and untreated prostate carcinomas were immunohistochemically analysed with regard to neuroendocrine (ne) differentiation using a monoclonal antibody against Chromogranin A. Density of ne-tumor cells/mm2 tumor area and arrangement of ne-tumor cells (single cells; small groups and large groups) were determined. We found ne-tumor cells in 90% of all carcinomas (n = 92). 70% had a low density of ne-tumor cells (< or = 1 cell/mm2). 67% of carcinomas with ne-differentiation showed only single ne-tumor cells, there were small groups in 19% and large groups in 14%. There was an association between higher densities of ne-tumor cells and arrangement in groups. In high malignancy carcinomas we found a higher density of ne-tumor cells and more often an arrangement in groups than in low grade tumors. Our results support reports in literature that ne-differentiation is of prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7511265

Source DB:  PubMed          Journal:  Verh Dtsch Ges Pathol        ISSN: 0070-4113


  5 in total

1.  An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers.

Authors:  Joseph E Ippolito; Jian Xu; Sanjay Jain; Krista Moulder; Steven Mennerick; Jan R Crowley; R Reid Townsend; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-05       Impact factor: 11.205

2.  [Relevance of the neuroendocrine differentiation in prostatic carcinoma].

Authors:  C G Sauer; L Trojan; R Grobholz
Journal:  Pathologe       Date:  2005-11       Impact factor: 1.011

3.  Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer.

Authors:  Jiaoti Huang; Jorge L Yao; Li Zhang; Patricia A Bourne; Andrew M Quinn; P Anthony di Sant'Agnese; Jay E Reeder
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

4.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 5.  Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells.

Authors:  Andrew S Goldstein; Tanya Stoyanova; Owen N Witte
Journal:  Mol Oncol       Date:  2010-07-14       Impact factor: 6.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.